Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin
- PMID: 6804577
- DOI: 10.1093/infdis/145.2.733
Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin
Abstract
The protective efficacies of bacille Calmette-Guérin (BCG) and Mycobacterium avium-intracellulare (MAI) were examined in guinea pigs that were infected by the respiratory route with one of three strains of Mycobacterium tuberculosis: two strains obtained as recent sputum isolates from an ongoing BCG trial in south India and laboratory strain H37Rv. Groups of animals were given all combinations of two treatments with BCG, MAI, or placebo and than challenged. The numbers of tubercle bacilli recovered from the primary lung lesions, primary lesion-free lung lobes, and spleens were used to estimate the relative protective effects of the various treatments. In general, BCG and MAI protected equally well against the low-virulence strain of M. tuberculosis. For the two more virulent strains the results were less clear; however, a substantial protective effect of MAI compared with BCG was noted. Infection with MAI did not significantly alter the capacity of BCG to protect against tuberculous infection.
Similar articles
-
Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.J Leukoc Biol. 2006 Dec;80(6):1262-71. doi: 10.1189/jlb.0606407. Epub 2006 Sep 12. J Leukoc Biol. 2006. PMID: 16968819
-
Influence of the virulence of Mycobacterium tuberculosis on protection induced by bacille Calmette-Guérin in guinea pigs.J Infect Dis. 1981 May;143(5):734-8. doi: 10.1093/infdis/143.5.734. J Infect Dis. 1981. PMID: 6787142
-
Immune response & modulation of immune response induced in the guinea-pigs by Mycobacterium avium complex (MAC) & M. fortuitum complex isolates from different sources in the south Indian BCG trial area.Indian J Med Res. 1996 Apr;103:201-11. Indian J Med Res. 1996. PMID: 8935740
-
Simple, practical ways to assess the protective efficacy of a new tuberculosis vaccine.Clin Infect Dis. 2000 Jun;30 Suppl 3:S250-3. doi: 10.1086/313870. Clin Infect Dis. 2000. PMID: 10875793 Review.
-
Nontuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.J Infect Dis. 2019 Aug 30;220(7):1091-1098. doi: 10.1093/infdis/jiz285. J Infect Dis. 2019. PMID: 31165861 Free PMC article. Review.
Cited by
-
Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer.Front Vet Sci. 2018 Oct 8;5:244. doi: 10.3389/fvets.2018.00244. eCollection 2018. Front Vet Sci. 2018. PMID: 30349823 Free PMC article. Review.
-
Effects of non-tuberculous mycobacteria on BCG vaccine efficacy: A narrative review.J Clin Tuberc Other Mycobact Dis. 2024 May 4;36:100451. doi: 10.1016/j.jctube.2024.100451. eCollection 2024 Aug. J Clin Tuberc Other Mycobact Dis. 2024. PMID: 38764556 Free PMC article. Review.
-
Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria.Infect Immun. 1984 Apr;44(1):28-32. doi: 10.1128/iai.44.1.28-32.1984. Infect Immun. 1984. PMID: 6423543 Free PMC article.
-
Isolation, PCR based identification, and sensitivity pattern of environmental mycobacteria from leprosy and tuberculosis patients.Indian J Clin Biochem. 2000 Jul;15(2):94-103. doi: 10.1007/BF02883735. Indian J Clin Biochem. 2000. PMID: 23105248 Free PMC article.
-
Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine.AIDS. 2010 Mar 13;24(5):675-85. doi: 10.1097/QAD.0b013e3283350f1b. AIDS. 2010. PMID: 20118767 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources